jili369 store
Trump trolls Trudeau as 'governor' of CanadaIf You’re Reading This, It’s A Sign You Deserve A Little Treat — Here Are 28 Of The Best Ones You Can Buy Yourself Right Now
Suriname rules out state funeral for ex-dictator BouterseTHE drums of war are beating. Vladimir Putin is threatening to incinerate all of us in a nuclear conflagration. In response, the feeble, cash-strapped European Union is struggling to raise an army after decades of feasting on an imaginary peace dividend. Alarm bells are sounding for the first time since the Cold War as Ukraine unleashes UK and US missiles deep inside Russia , raising the risk of pan-European conflict. Scary times. But are we really facing World War Three ? To quote Dad’s Army’s Lance Corporal Jones: “Don’t panic!” Read More on World News At least, not yet. Still, frontline states such as Sweden, Denmark, Norway and Finland are taking the threat seriously. Peacenik Germany has finally woken up to the Russian menace and invited 800,000 Nato troops to carry out war games on its soil. In America, you can buy “affordable bunkers to survive the apocalypse now — fallout shelters that won’t break the bank” — at $140,000 a pop. Most read in The Sun Here in Britain, an online newspaper captures the mood with survival tips such as: “How to stop your skin melting” and “Why you should keep your mouth open so your eardrums don’t burst . . .” One misstep away from global conflict Nothing sells better than a horror story. The truth is that the world is paying dearly for the absurd 76-day power gap between Donald Trump’s election as US President on November 5 and his inauguration on January 20 . The vacuum is being filled by sabre-rattling as both sides in the Ukraine conflict strive to make irreversible gains before Trump enters the White House . The crisis has been stoked by doddery Joe Biden , who belatedly handed Ukraine the long-range missiles it might have previously used to end the war. Instead, President Volodymyr Zelensky’s attacks deep inside Russia have provoked the Kremlin into threatening nuclear retaliation. On Thursday, after hitting the Ukrainian city of Dnipro with a nuke-capable hypersonic Oreshnik missile, Putin declared the UK and US could now be targets for Russia. We need to calm down. Even Mad Vlad is not crazy enough to nuke the West. And if he were, China wouldn’t let him. Moscow and Beijing may be joined at the hip in seeking to hobble the mighty American colossus. But Beijing dictator Xi Jinping intends to achieve this by stealth and coercion — not by letting his junior partner unleash Apocalypse Now. This is not to understate the unnervingly sinister risk to world peace. We have learned from two catastrophic world wars — and the 1962 Cuban Missile Crisis — that we are always just one hideous misstep away from global conflict. Amid this crisis, we find ourselves in the hands of the most unpredictable and erratic world leader of modern times. Donald Trump has stoked tensions by threatening to turn the world’s economic, diplomatic and military order on its head. He is ready to crack heads together in the Middle East , sink China’s exports and launch trade wars with Europe. But first up, Ukraine. The 47th President-elect is ready to walk away from a European conflict which he insists has absolutely nothing to do with the US. Yet while European Union leaders have dithered and wrung their hands, American taxpayers forked out £140BILLION in aid and arms to Ukraine. Enough is enough, says Trump. This might be a bluff by the world’s biggest bluffer. But only a fool would call it. Which explains why Kyiv leader Zelensky is grabbing every weapon he can lay hands on to beat off the Russian bear while he still has time. They include the long-range American ATACMS and, thanks to PM Keir Starmer , Britain’s lethal Storm Shadow cruise missiles , already deployed with devastating effect this week. And yet, admirable as this may be in defence of brave Ukraine, it merely prolongs an unwinnable war. Putin, himself a formidable negotiator, has raised the stakes by insisting foreign-made weapons used against Russia are grounds for nuclear retaliation . This leaves the EU dangerously exposed. Despite the overlapping membership of Nato, the EU’s 27 member states have become flabbily impotent. For half a century, taxpayers’ trillions have been lavished on social-welfare spending while mere pennies have been set aside for the military. Armies are depleted while naval and air defences are running on fumes. In the face of the biggest threat to peace since World War Two , Europe today stands effectively defenceless. During his first term of office, President Trump put a bomb under EU leaders, making them cough up more cash for military spending. But not enough. Germany, which once armed its troops with broomsticks instead of rifles, is the worst culprit. Despite its role as the EU’s economic dynamo, the Ukraine conflict has shown it was totally dependent on Russian oil and gas. Now, with the heat on, Berlin is offering to host 800,000 Nato troops on its soil to defend the Fatherland if Russia invades Finland or the Baltic states. Under Article 51 of the Nato alliance, an attack on any of its 32 member nations is deemed an attack on all. Formerly pacifist regimes now understand the only way to preserve peace is to prepare for war. In 1960s, we practised diving under the table Late in the day, Europe’s liberal elites in countries such as Sweden and Holland have ordered industrial and agricultural interests to stockpile food, fuel and vital equipment including diesel generators. Which underscores the madness of Keir Starmer’s declaration of war on Britain’s hard-pressed farmers. We may soon need every acre to plant crops and dig for victory. Nor can Labour now justify its decision to mothball our coal, gas and oil resources at a time of soaring energy prices in pursuit of Ed Miliband’s insane Net Zero deadline. Voters will also ask why this Government is scrapping five Royal Navy warships, dozens of military helicopters and drones and perhaps even our two brand-new aircraft carriers. If our plodding PM has learned anything from his never-ending overseas meetings with world leaders, it is surely that socialism is no substitute for a proper defence policy. We have been through similar crises in the past, not least the decades-long Cold War when the Kremlin really did pose a nuclear threat to our survival. In the 1960s we lived with the possibility of imminent attack, heralded only by a “four-minute warning” on old war-time sirens. We practised diving under the dining room table, or standing in doorways which are more likely to survive a blast. The best-selling book On The Beach portrayed Aussies awaiting their “last days on Earth” after a nuclear war in the northern hemisphere. Peter Sellers made us laugh nervously in Dr Strangelove Or: How I Learned To Stop Worrying And Love The Bomb. Women protesting against Polaris missiles camped out for years at RAF Greenham Common, while “Red Ken” Livingstone fatuously declared London a “nuclear-free zone”. By the 1980s, East-West negotiations reached the basis for an uneasy truce. It was literally MAD — “Mutually Assured Destruction”. Press the red button and we all die. In my early days as The Sun’s Political Editor, I accompanied PM Margaret Thatcher to Moscow for various talks with Soviet leaders. I had a ringside seat at one of the most significant disarmament summits between Russia’s Mikhail Gorbachev and American President Ronald Reagan . The superpower leaders agreed on huge, if symbolic, missile cuts, captured on Page One of The Sun by an image of nukes launched harmlessly into the Pacific Ocean. “We reaffirmed our solemn conviction that a nuclear war cannot be won and must never be fought,” said the two world leaders in 1988. The Berlin Wall fell one year later, marking the so-called End Of History. But nuclear weapons cannot be disinvented. Mutually Assured Destruction remains the only bulwark against Armageddon. Luckily, Donald Trump is a master of The Art Of The Deal. Putin is desperate to be treated with respect on the world stage, not as a global pariah. For all his bombast, he knows his country has suffered disastrous losses in blood and treasure from his blundering assault on Ukraine. Tough call for so-called European superstate Sanctions have blocked Russia’s stagnant economy from Western advances in technology. A permanent ceasefire is negotiable, but only if Putin is not humiliated. There could be deals which revive Russia’s lucrative trade in oil and gas. Putin will want to be re-admitted to the top table of the world’s most powerful economies, making the G7 into the G8 once again. Brave Ukraine cannot fight on without allied support. Nor should it be abandoned to exist in a “frozen war”, perpetually intimidated by Russia. Which is where the European Union must step in. Ukraine is now Europe’s responsibility, not America’s. The EU’s member states must find the resources to guard their own borders. They can rely on Nato — which includes the US and UK — but only if they raise defence spending by billions. This is a tough call for the so-called European superstate, which has spent the past five decades effectively disarming. READ MORE SUN STORIES A failure of will at this crucial point would be disastrous. If Putin digs his heels in on Ukraine, we might yet find ourselves buying “affordable bunkers to survive the apocalypse”.
THOUSAND OAKS, Calif. , Dec. 10, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for the first quarter of 2025. The dividend will be paid on March 7, 2025 , to all stockholders of record as of the close of business on February 14, 2025 . About Amgen Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions . Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ® , and it is also part of the Nasdaq-100 Index ® , which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. For more information, visit Amgen.com and follow Amgen on X , LinkedIn , Instagram , TikTok , YouTube and Threads . Forward-Looking Statements This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company (including BeiGene, Ltd. or Kyowa Kirin Co., Ltd.), the performance of Otezla® (apremilast) (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of Teneobio, Inc., ChemoCentryx, Inc., or Horizon Therapeutics plc (including the prospective performance and outlook of Horizon's business, performance and opportunities, any potential strategic benefits, synergies or opportunities expected as a result of such acquisition, and any projected impacts from the Horizon acquisition on our acquisition-related expenses going forward), as well as estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes, effects of pandemics or other widespread health problems on our business, outcomes, progress, and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future products, sales growth of recently launched products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions. In addition, sales of our products are affected by pricing pressure, political and public scrutiny and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market. Our business may be impacted by government investigations, litigation and product liability claims. In addition, our business may be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. If we fail to meet the compliance obligations in the corporate integrity agreement between us and the U.S. government, we could become subject to significant sanctions. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico , and also depend on third parties for a portion of our manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, such as COVID-19, and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the distribution of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product development, product sales, business and results of operations. We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed products as well as for the discovery and development of new products. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful. There can be no guarantee that we will be able to realize any of the strategic benefits, synergies or opportunities arising from the Horizon acquisition, and such benefits, synergies or opportunities may take longer to realize than expected. We may not be able to successfully integrate Horizon, and such integration may take longer, be more difficult or cost more than expected. A breakdown, cyberattack or information security breach of our information technology systems could compromise the confidentiality, integrity and availability of our systems and our data. Our stock price is volatile and may be affected by a number of events. Our business and operations may be negatively affected by the failure, or perceived failure, of achieving our environmental, social and governance objectives. The effects of global climate change and related natural disasters could negatively affect our business and operations. Global economic conditions may magnify certain risks that affect our business. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all. CONTACT: Amgen, Thousand Oaks Elissa Snook , 609-251-1407 (media) Justin Claeys , 805-313-9775 (investors) View original content to download multimedia: https://www.prnewswire.com/news-releases/amgen-announces-2025-first-quarter-dividend-302328180.html SOURCE Amgen
Parkit Enterprise (CVE:PKT) Stock Price Down 3.5% – Time to Sell?
Georgia Tech cruises past Alabama A&MHomes vs. beaches: Court makes key decision in battle over California seawall construction amid ocean rise
Woolworths strike: Distribution centre action has so far cost grocery giant $50m in lost food salesFinally, Time for California to Get Real on High-Speed Rail
The groundbreaking blockchain-based platform Rexas Finance (RXS) has mesmerized the cryptocurrency market. Designed to transform real estate tokenization into decentralized finance (DeFi), this altcoin mainly attracts big-money investors. Due to its exceptional performance and innovative use cases, Rexas Finance is quickly becoming a leading candidate to surpass market leaders Solana (SOL) and Ripple (XRP) by 2025. Rexas Finance (RXS): The Altcoin Drawing Attention From Investors Rexas Finance primarily distinguishes itself from competitors such as Solana and Ripple by prioritizing practical applications. Solana shines in fast blockchain transactions and Ripple in cross-border payments; Rexas Finance presents a special offer by combining DeFi with physical assets. With this strategic differentiator, it stands out as a solution that can adapt to the constantly shifting blockchain ecosystem with greater versatility and impact. Fundamentally, Rexas Finance tokenizes actual assets like property using innovative blockchain technology. This invention lets consumers access quick, open, safe financial services. By bridging the gap between traditional assets and scattered ecosystems, Rexas Finance redefines investor interaction with real estate. Tokenization enables fractional ownership, making high-value assets more reachable to a larger audience and boosting liquidity in an inactive sector. Rexas Finance is positioned to gain from the $486 trillion worldwide financial asset market with a market span including real estate, commodities, and financial assets. Its ETH-based token properties provide even more appeal and position RXS for a possible 10000% rise following launch. It started stage 11 of its presale at an astounding $0.175. With about 380 million tokens sold, the presale currently brings in over $33.1 million. These numbers highlight investors' rising faith in the platform's ability to provide significant profits. Rexas tokens are highly sought after because of their creative approach to DeFi and real estate tokenizing, which distinguishes them from other cryptocurrencies. Rexas Finance's listings on CoinMarketCap and CoinGecko confirm its reliability even further. These sites are reliable sources of cryptocurrency data, and their respect for Rexas Finance emphasizes its validity and commercial applicability. Furthermore, top blockchain security company Certik has closely examined the initiative. Attracting institutional investors depends on Rexas Finance following the best standards of security and openness; hence, this accreditation guarantees these aspects. Investing in the RXS presale is easy and offers a chance to get tokens before the price hikes. Popular altcoins anticipated to develop quicker than Solana and Ripple are attracting enormous sums of money. Go to the official Rexas Finance website to guarantee a safe transaction and avoid fraud. Purchase RXS with defined tokens like Ethereum or USDT after linking your wallets—such as MetaMask or Trust Wallet. Once bought, keep your tokens in your wallet and monitor the presale stages to remain current on price adjustments and advancement. Rexas Finance has started a continuous $1 million giveaway to improve its community involvement further. Twenty fortunate members of this program will receive $50,000 of Rexas tokens apiece. Such rewards show the platform's dedication to honoring fans and promoting long-term devotion. Along with raising awareness, the offer draws a diverse spectrum of investors, from institutional players to retail consumers. Moreover, the significant money gathered during its presale and the increasing community support point to a strong basis for ongoing expansion. Rexas Finance is unique in its ability to provide innovation and practical value as the market increasingly embraces utility-driven initiatives. Conclusion With its ambitious ambition and established track record, Rexas Finance is well on its way to becoming a significant cryptocurrency market participant. The platform's capacity to tokenize real estate and link it with DeFi is consistent with the growing desire for practical blockchain applications. Furthermore, its recent accomplishments, such as raising over $33.1 million, listing on key platforms, and undergoing a Certik audit, demonstrate its ability to compete with industry titans. Investors seeking substantial growth should pay close attention to Rexas Finance. For investors looking to profit from the next wave of blockchain developments, its presale success, continuous activities, and creative use cases make it a convincing option. As it continues to gather momentum, Rexas Finance could beat Solana and Ripple extremely effectively and become a major player in the crypto market by 2025. Website: https://rexas.com Win $1 Million Giveaway: https://bit.ly/Rexas1M Whitepaper: https://rexas.com/rexas-whitepaper.pdf Twitter/X: https://x.com/rexasfinance Telegram: https://t.me/rexasfinance Join our WhatsApp Channel to get the latest news, exclusives and videos on WhatsApp _____________ Disclaimer: Analytics Insight does not provide financial advice or guidance. Also note that the cryptocurrencies mentioned/listed on the website could potentially be scams, i.e. designed to induce you to invest financial resources that may be lost forever and not be recoverable once investments are made. You are responsible for conducting your own research (DYOR) before making any investments. Read more here.After starting 2-0 in its inaugural Atlantic Coast Conference schedule, SMU looks to make the month even more special on Sunday, hosting Longwood in Dallas, Texas. The Mustangs seek a seven-game win streak in their final nonconference test before welcoming No. 4 Duke to Dallas on Jan. 4. In recent victories over Alabama State, Virginia, LSU, and Boston College, SMU (10-2) averaged 85.3 points per game, allowed just 66.0 ppg, and climbed to No. 30 in the NET rankings. "We're a different team right now than we were earlier in the season," SMU head coach Andy Enfield said at the beginning of December, his words ringing even truer as the season progresses. "They'd never been under pressure together until recently, so they're starting to learn and figure things out." Longwood (11-3) enters its third consecutive road game, having won five of its last six overall. That includes a major 82-67 win at North Carolina Central on Dec. 20. It was only the sixth nonconference home loss for NCC since 2016, and Longwood head coach Griff Aldrich saw it as a result of his team's growing cohesiveness. "We got great contributions from so many players," Aldrich said. "We have been working to play more and more connected, and this team has really taken positive steps this week." The Mustangs' Matt Cross is among the biggest threats to Longwood's defense, which allows just 66.6 points per game. A 6-foot-7 forward, Cross had 36 points over SMU's last two wins, including a 16-point, 16-rebound double-double against LSU. What Cross does with the ball in his hands is impressive -- he is averaging 13.5 ppg in December -- but it is also what he does off the ball that increases his value. "He's extremely tough," Enfield said after Cross' performance against LSU. "His wall up in transition, where (Corey) Chest came down, was going to dunk the ball, and he stood there and took the contact. ...That's a big-time basketball play." Longwood is paced by Michael Christmas, a veteran forward in his fourth year in the program. A hard-nosed wing who can score at all three levels, Christmas is Longwood's only returner who started at least 30 games on last year's NCAA Tournament team. He is averaging a team-high 11.9 points per game. "(He) loves this university, loves this town and community," Aldrich said of Christmas. "He opted to come back here to really invest in the program." --Field Level Media
I’m A Celebrity’s Ant and Dec made a cheeky swipe at Dean McCullough following a rule break as fans were left in stitches.The radio host has become one of the most talked-about contestants this year after dramatically quitting trials early. And last night, the star was caught breaking show rules as he was seen slipping a teabag into a pot of boiling water, leaving hosts Ant and Dec unimpressed. During Friday’s (November 22) episode of the ITV hit reality show, Danny and Dean headed down to the Bushtucker Trial area to face ‘The High Street of Horrors’. Horrified to learn they'd be joining them there, Maura and Richard also headed down to the Trial area for the day’s Bushtucker Trial, not knowing what lay in store. First to arrive were Maura and Richard and they were greeted by Ant and Dec and asked how they were enjoying the Jungle Junkyard. Ant and Dec explained to the duo that as they successfully got a bed delivered to them from main camp yesterday, they won three portions of food for the junk food buffet. They were also told that the Trial was their next opportunity to continue the charade, as they had to convince Danny and Dean that they had already taken part in ‘The Deadly Department Store’ to try and win 2 stars for their dinner, but failed. Maura and Richard both got stuck into the pretence, as they covered one another in feathers and molasses and put on their best acting performance. As Dean and Danny entered Ant joked: "Dean welcome once again. Two out of the last three you shouted ' I'm a Celebrity Get Me Out of Here. I'm not angry anymore just disappointed." Ant then told Dean and Danny what they were due to face in their part of the Trial. There were three shops, each containing a number of stars to win for camp. All they had to do was find them within the time allocated for their shopping spree. Dean and Danny stopped at the ‘Grim Grocers’ first, where there were three stars on offer and they had three minutes to find them. When the klaxon sounded, an eager Danny was in such a hurry to get into the shop, he tripped over. Plus, Dean had to come face-to-face with his arch nemesis - fish guts. Winning two stars for camp, they proceeded to the ‘Electrifying Electrical store’ where they picked up a further two stars out of three, within the three minute time slot. The star they missed was revealed by Ant and Dec to be hiding in the kettle, as they teased Dean: “We thought you’d have gone straight for the kettle, we know you love a cup of tea!” Viewers were quick to pick up on the dig after Deans rule break as they went straight to social media to share their reaction. One viewer took to X, formerly known as Twitter and said: “THE TEA SHADEEE I CANT #ImACeleb.” Another commented: “Ant and dec are absolutely trolling dean now with stars in the kettle #ImACeleb A third joked: ““How do you they know about the tea?” DEAN YOU ARE LITERALLY ON A REALITY SHOW WITH CAMERAS FILMING 24/7 #ImACeleb.” One said: “We know how much you like a cup of tea dean? #ImACeleb.” Meanwhile another added: “THEY PUT THE STAR IN THE KETTLE AHAHAHAHA DANNY IS LOVING THE TEA JOKES #ImACeleb.” I’m A Celebrity...Get Me Out Of Here! returns tomorrow at 9pm on ITV1 and ITVX
Current President Chan Santokhi "has decided, based on his powers and advice received, that there will be no state funeral... No period of national mourning," Foreign Minister Albert Ramdin told a press conference. Bouterse was a former military man who twice mounted coups, in 1980 and again in 1990, to take charge as a dictator. He eventually returned to power after being elected president in 2010 and governed for a decade. He died Tuesday in the unknown location where he had been holed up as a fugitive, with in-absentia convictions for cocaine trafficking and murder. Bouterse's body was dropped off at his residence in the capital Paramaribo. An autopsy was ordered, though police said there were "no signs of criminal activity." Bouterse had been sentenced to 20 years in prison in December 2023 for the 1982 execution of political opponents, including lawyers, journalists, businessmen and military prisoners. He remained a popular figure with the poor and working class in the former Dutch colony. The foreign minister said that, out of respect for Bouterse's status as an elected former president, flags would be flown at half-staff on government buildings on the day of his funeral, whose date has not yet been given. str-jt/rmb/acbCyber Monday shoppers expected to set a record on biggest day for online shopping